Purpose Several studies have suggested an association between the polymorphisms AhR Arg554Lys, AhRR Pro185Ala, and ARNT Val189Val and endometriosis, but results have been inconclusive. The aim of the present study was to assess these associations by meta-analysis. Methods Eligible literatures were retrieved from PubMed, ISI Web of Science, Elsevier Science Direct, and several Chinese databases. The pooled odds ratios (ORs) and the corresponding 95 % confidence intervals (CIs) were calculated with a random or fixed-effect model. Results A total of six eligible studies were included. Regarding the AhR Arg554Lys and ARNT Val189Val polymorphisms, no obvious associations were found in either overall analysis or subgroup analysis based on the country, source of control, sample size, and genotyping method. For the AhRR Pro185Ala polymorphism, overall results suggested a marginal association with endometriosis susceptibility under the dominant model (OR=1.65, 95 % CI=1.00-2.72). Furthermore, a significantly increased risk for endometriosis was found in the subgroups which used the TaqMan method for genotype analysis or had a sample size ≥200. Conclusions This meta-analysis suggested that the polymorphisms of AhR Arg554Lys and ARNT Val189Val are not associated with endometriosis, while the AhRR Pro185Ala polymorphism may be associated with endometriosis risk. However, further case-control studies with larger sample sizes are needed to confirm our results.
Introduction
Endometriosis is a common gynecological disease defined as the occurrence of endometrial glands and stroma outside of the uterine cavity with diverse symptoms, such as dysmenorrhea, infertility, and chronic pelvic pain [1, 2] . The most common lesion locations of endometriosis are the peritoneum, ovaries, utero-sacral ligaments, and pouch of Douglas. Although retrograde menstruation of endometrial cells and their subsequent attachment in the pelvic cavity is the primary explanation for the pathogenesis of endometriosis, this hypothesis is inadequate considering that retrograde menstruation occurs in up to 90 % of menstruating women with patent fallopian tubes while the prevalence of endometriosis is much lower [3] . There is growing evidence that endometriosis is likely a multifactorial disease. Complex interactions between genetic, immunologic, hormonal, and environmental factors likely contribute to the pathogenesis of endometriosis [4] [5] [6] . However, the exact etiology and pathogenesis of the disease remain unclear.
Recently, epidemiological investigations and animal experiments have shown that exposure to environmental contaminants may contribute to endometriosis susceptibility [7, 8] . According to previous studies, dioxins are a typical environmental contaminate stimulating the growth of endometrial lesions and increasing the risk of endometriosis [8, 9] . The aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor localized to cytoplasm. When bound to dioxin ligands, AhR translocates from the cytoplasm to the nucleus and heterodimerizes with AhR nuclear translocator (ARNT), contributing to the activation of target genes by binding to the xenobiotic response element [10, 11] . Activation of these pathways may give rise to endocrine abnormality, immunotoxicity, and even cause cancer [11, 12] . The AhR repressor (AhRR) regulates AhR signaling by competing for dimerization to ARNT to downregulate gene expression [13] . AhR, ARNT, and AhRR are all expressed in the female reproductive system and can change expression under specific pathologic conditions [14] . Based upon the possible contribution of dioxin to the pathogenesis of endometriosis, it has been hypothesized that variants of the AhR, ARNT, and AhRR genes which affect the xenobiotic detoxification process may also be associated with the risk of endometriosis.
A number of previous studies have investigated the association between the AhR Arg554Lys (AGA to AAA, codon 554 in exon 10), AhRR Pro185Ala (CCC to GCC, codon 185 in exon 5), and ARNT Val189Val (GTG to GTC, codon 189 in exon 7) polymorphisms and endometriosis in Asian populations [15] [16] [17] [18] [19] [20] but have failed to reach a definite conclusion. Each of these studies was limited by inclusion of only one ethnic group and a small sample size. Therefore, we conducted a meta-analysis combining currently available data to examine the association between the AhR Arg554Lys, AhRR Pro185Ala, and ARNT Val189Val polymorphisms and endometriosis.
Materials and methods

Publication search
To collect eligible literature, we conducted a systematic search in PubMed, ISI Web of Science, Elsevier Science Direct, and several Chinese databases (Biomedical Literature Database, Chinese National Knowledge Infrastructure, and Chinese Wanfang Data) using different combinations of the following search terms: BAryl hydrocarbon receptor^or BAhR,^BAhR repressor^or BAhRR,^BAhR nuclear translocator^or BARNT, and Bpolymorphism^or Bvariation^or Bvariant^or Bmutation^and Bendometriosis^. There was no language restriction, and the last search was updated on February 15, 2015. All references listed in the eligible studies were checked for other relevant literature. All clearly irrelevant studies, case reports, and editorials were excluded. Review articles were also searched to avoid omission of any potential relevant studies.
Inclusion and exclusion criteria
Studies meeting the following criteria were included in the meta-analysis: (1) The study was a case-control design conducted in humans; (2) the study assessed the relationship between the polymorphisms of AhR Arg554Lys, AhRR Pro185Ala, and ARNT Val189Val and endometriosis; and (3) the study provided sufficient genetic information to calculate the odds ratio (OR) and its corresponding 95 % confidence interval (CI). Studies were excluded based on the following criteria: (1) The study was not relevant to the association of the polymorphisms AhR Arg554Lys, AhRR Pro185Ala, and ARNT Val189Val with endometriosis; (2) no useful data were provided on genetic polymorphisms; (3) the study was not clinical; and (4) the study was a review article or commentary.
Data extraction
The following information was extracted from every eligible study: Name of first author, year of publication, country of origin, ethnicity of the study population, number of cases and controls, mean age of subjects and controls, the source of control, the genotyping method, genotype distributions in cases and controls, and probability (p) value for the test of Hardy-Weinberg equilibrium (HWE) in controls.
Quality evaluation
The quality of every included study was assessed according to the Newcastle-Ottawa scale (NOS). The NOS consists of three parts with nine items (one point for each item): selection of the study groups (four items), comparability of the groups (two items), and outcome measurements (three items) [21] . A score greater than 5 was regarded as high quality; otherwise, the study was considered low quality [22] .
Statistical analysis
Data analysis was performed using STATA statistical software (version 12.0; Stata Corporation, College Station, TX, USA). ORs with their corresponding 95 % CIs were calculated to estimate the strength of the association of the AhR Arg554Lys, AhRR Pro185Ala, and ARNT Val189Val polymorphisms with endometriosis. Analysis of the polymorphisms was conducted in at least two studies. The pooled OR was calculated for the allele model, homozygote comparison, heterozygote comparison, dominant model, and recessive model. The significance of the pooled OR was determined by Z test, and a p<0.05 was considered statistically significant [1] . The heterogeneity among eligible studies was calculated by chi-square-based Q test [23] . The existence of heterogeneity was regarded as significant at p<0.1; in which case, a random-effect model using the DerSimonian-Laird method was applied [24] . Otherwise, a fixed-effect model (Mantel-Haenszel method) was used to calculate the pooled OR [25] . To explore the reasons for heterogeneity, subgroup analyses were applied based on the country, source of control, genotyping method, and sample size. In addition, sensitivity analyses were performed to validate the credibility of outcomes in this meta-analysis by deleting single studies one at a time [26] . The publication bias was evaluated by Begg's test and Egger's test and was regarded as statistically significant when p<0.05 [27, 28] .
Results
Characteristics of eligible studies
A total of 56 published articles were identified as potentially relevant through our search strategy, with 32 articles excluded for duplication. After review of the abstracts and titles from the remaining articles, 11 studies were eliminated because they were not related to AhR, ARNT, AhRR, or endometriosis. Of these studies, seven articles were excluded because they (1) were reviews, (2) lacked meaningful data, (3) were without controls, or (4) were not human studies. In the end, a total of six studies were included in this meta-analysis. A flow chart of the inclusion/exclusion steps applied to studies is displayed in Fig. 1 , and characteristics of the eligible studies are listed in Table 1 . All of the identified studies were considered high quality (NOS>5) and did not deviate from HWE (p>0.05). Among the six eligible studies, five studies examined the AhR Arg554Lys polymorphism, five studies examined the AhRR Pro185Ala polymorphism, and three studies concerned the ARNT Val189Val polymorphism. However, the article by Matsuzaka et al. [17] only provided data on allele frequency, while data from Wu et al. [18] were based on the dominant model alone. In the current study, although the association of endometriosis with the AhR Arg554Lys, AhRR Pro185Ala, and ARNT Val189Val polymorphisms was assessed under all five genetic models, we have only shown the overall and subgroup results under the allele and dominant models in Table 2 .
Association of AhR Arg554Lys polymorphism and endometriosis
A total of 776 cases and 980 controls were included to assess the association between the AhR Arg554Lys polymorphism and risk for endometriosis. Overall results from the five No useful data (n=2); Without control (n=1); Reviews (n=3); Not human studies (n=1).
Studies included in qualitative synthesis (n = 6)
ANRT Val189Val (n = 3) Fig. 1 The study selection process Fig. 2 ).
Association of AhRR Pro185Ala polymorphism and endometriosis
A total of five studies with 661 cases and 737 controls were identified to evaluate the association between the AhRR Pro185Ala polymorphism and endometriosis risk. Table 2 , Fig. 3 ).
Association of ARNT Val189Val polymorphism and endometriosis
Three studies with 631 cases and 729 controls were included to examine the association between the ANRT Val189Val polymorphism and risk of endometriosis. Under all genetic models, no significant association was found when all studies were pooled into the meta-analysis (allele model: OR=1.14, 95 % CI=0. Subsequent subgroup analyses also showed no statistically significant association between this polymorphism and endometriosis risk (Table 2 , Fig. 4 ).
Heterogeneity test and sensitivity analysis
In studies examining the association of the AhR Arg554Lys and ARNT Val189Val polymorphisms with endometriosis, there was no heterogeneity among studies in overall comparisons (p>0.10). However, for the AhRR Pro185Ala polymorphism studies, between-study heterogeneity was statistically significant (p<0.10). To explore sources of heterogeneity across studies, subgroup analyses based on the country, source of control, genotyping method, and sample size were conducted, but none of these variables were able to explain the heterogeneity. In order to assess the stability our meta-analysis results, sensitivity analyses were applied by deleting one study at a time. This procedure confirmed that our results regarding the association of the AhR Arg554Lys, ARNT Val189Val, and AhRR Pro185Ala polymorphisms and endometriosis susceptibility were both reliable and robust (Fig. 5) .
Publication bias
Begg's test and Egger's test were performed to evaluate potential publication bias among studies included in this metaanalysis. Results showed no publication bias for the studies we examined (p>0.05).
Discussion
Endometriosis is a complicated pathological condition which is not fully understood. It has recently been noted that the incidence of endometriosis among reproductive-aged women is increasing [19] . A large number of studies have been conducted to explore the correlation of genetic mutations, including the AhR Arg554Lys, AhRR Pro185Ala, and ANRT Val189Val polymorphisms, with endometriosis, but results have not been consistent even in the same population. Therefore, our meta-analysis should be of great value in identifying the association of AhR Arg554Lys, AhRR Pro185Ala, and ANRT Val189Val polymorphisms with endometriosis risk.
To the best of our knowledge, this is the first meta-analysis to assess the relationship between these three gene polymorphisms and risk of endometriosis. Our meta-analysis failed to find a significant association between the AhR Arg554Lys and ARNT Val189Val polymorphisms and endometriosis susceptibility in the overall population and in further subgroup analyses. However, it is worth mentioning that the present metaanalysis was limited to the Asian population. Inconsistent results might be obtained from different genetic backgrounds in different ethnicities. Furthermore, for complex gynecologic conditions such as endometriosis, gene-environmental interactions may be more important and relevant than genetic background alone [29, 30] . Further studies in other ethnic groups, such as Caucasian populations, may help to fully understand the influence of these polymorphisms on endometriosis susceptibility. Additionally, in this meta-analysis, the majority of studies enrolled control subjects from women who were hospitalized with the absence of endometriosis and not from healthy volunteers. In fact, two of the studies [15, 17] recruited controls with health histories of unexplained infertility, which may have produced unreliable results because hospital-based controls are less representative of the general population, particularly when the disorders that hospital-based controls may have are expected to be related to the polymorphisms under investigation [31, 32] .
For the AhRR Pro185Ala polymorphism, we did find a marginal association with endometriosis in the overall population under the dominant model. Furthermore, this polymorphism was significantly associated with endometriosis using the TaqMan genotyping method under all genetic models. One possible explanation is that different genetic methods vary in sensitivity and specificity. It was reported that TaqMan, gene chip, and mass array genotyping methods provide the best sensitivity and accuracy in single-nucleotide polymorphism (SNP) genotyping under optimized condition [33] [34] [35] , and use of less sensitive methods may have produced discrepant results. The results of our study also showed that the association of the AhRR Pro185Ala polymorphism and endometriosis was statistically significant when the sample size was equal to or greater than 200 under the dominant model. As the limited study numbers and relatively small sample sizes may have resulted in small study bias [36] , large-scale studies are necessary to further confirm the association between AhR Arg554Lys, AhRR Pro185Ala, and ARNT Val189Val polymorphisms and endometriosis risk.
Although no significant association was found between the AhR Arg554Lys and ARNT Val189Val polymorphism and endometriosis susceptibility in the present study, the combination of AhR with dioxins has been shown to cause high expression of target genes including cytochrome P450 1A1 (CYP1A1), which is considered harmful because it creates active oxygen and mutagenic metabolites [37] . The level of CYP1A1 expression was reported greater in patients with endometriosis than in a non-endometriosis control group [38, 39] . AhR signaling is regulated in part by AhRR, which is located in the nucleus and functions to downregulate AhR interaction with ARNT. The exact mechanism controlling the association between the AhRR polymorphism and endometriosis is still unclear, but it has been shown that AhRR polymorphisms altered AhR-mediated signaling [40] . Therefore, loss or reduction of AhRR expression in cells may result in increased susceptibility to the toxic effects of dioxins by reducing the negative regulatory effects of AhRR [20] and may facilitate proliferation of endometrial cells through diminished downregulation of AhR-mediated signaling [18] . Some limitations should be noted in this meta-analysis. First, the results of our meta-analysis should be interpreted with caution because the number of studies and the sample sizes used in the studies were relatively small. There were only six studies included in our meta-analysis, and two of the studies [17, 18] presented data based on a single genetic model, which limited our ability to conduct more meaningful subgroup analyses. Second, the pooled results were based on unadjusted estimates, and potential covariates which might influence the effect estimates were not controlled for the lack of information. Third, between-study heterogeneity was significant in studies of the AhRR Pro185Ala polymorphism, even though sensitivity analysis demonstrated no substantial impact of a single study on the overall results. Thus, further studies with larger sample sizes will be required to provide more detailed information on the relationship between genetic polymorphisms and endometriosis susceptibility.
Conclusions
In summary, the results of this meta-analysis indicate that the AhRR Pro185Ala polymorphism may be associated with the endometriosis, while the AhR Arg554Lys and ARNT Val189Val polymorphisms are not likely associated. It is critical that large-scale and well-designed studies be performed to re-evaluate these potential relationships. 
